ORKA Oruka Therapeutics, Inc.
$84.52
Oruka Therapeutics, Inc. (ORKA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
Bearish
Selling ran elevated versus ORKA's own trailing one-year pace, with 7% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
79 transactions
Purchases
$0
0 shares
Sales
$324.5M
3,869,045 shares
Net activity
-$324.5M
purchases less sales
How much of that selling was preplanned? 7% planned / 93% discretionary
10b5-1 plan sales
$23.7M
68 transactions · 305,327 shares
Discretionary sales
$300.9M
11 transactions · 3,563,718 shares
Largest single sale: $300.0M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Quinlan Paul T 4 fills | General Counsel | Sell 10b5-1 | 10,000 | $93.64 | $936.4K | 37,095 −21.2% of holding | |
| Agarwal Arjun | Senior Vice President, Finance | Sell 10b5-1 | 533 | $95.75 | $51.0K | 14,219 −3.6% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $91.93 | $643.5K | 37,334 −15.8% of holding | |
| Klein Lawrence Otto | Chief Executive Officer | Sell | 2,452 | $95.71 | $234.7K | 923,128 −0.3% of holding | |
| Quinlan Paul T | General Counsel | Sell | 1,039 | $95.71 | $99.4K | 29,995 −3.3% of holding | |
| Goncalves Joana | Chief Medical Officer | Sell | 947 | $95.71 | $90.6K | 31,771 −2.9% of holding | |
| Sandler Laura Lee | Chief Operating Officer | Sell | 906 | $95.71 | $86.7K | 235,478 −0.4% of holding | |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 560 | $95.71 | $53.6K | 14,752 −3.7% of holding | |
| Agarwal Arjun 4 fills | Senior Vice President, Finance | Sell 10b5-1 | 9,459 | $92.23 | $872.4K | 21,771 −30.3% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $111.84 | $782.9K | 38,818 −15.3% of holding | |
| Quinlan Paul T 6 fills | General Counsel | Sell 10b5-1 | 52,000 | $108.49 | $5.6M | 79,404 −39.6% of holding | |
| Agarwal Arjun 5 fills | Senior Vice President, Finance | Sell 10b5-1 | 10,000 | $106.66 | $1.1M | 23,212 −30.1% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $86.28 | $603.9K | 39,318 −15.1% of holding | |
| Agarwal Arjun 4 fills | Senior Vice President, Finance | Sell 10b5-1 | 9,999 | $84.63 | $846.2K | 25,011 −28.6% of holding | |
| Sell | 3,553,410 | $84.43 | $300.0M | 1,131,954 −75.8% of holding | |||
| Sandler Laura Lee 3 fills | Chief Operating Officer | Sell 10b5-1 | 5,000 | $94.42 | $472.1K | 239,147 −2% of holding | |
| Agarwal Arjun 2 fills | Senior Vice President, Finance | Sell 10b5-1 | 1,587 | $80.95 | $128.5K | 16,011 −9% of holding | |
| Goncalves Joana 3 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $69.23 | $484.6K | 39,029 −15.2% of holding | |
| Klein Lawrence Otto | Chief Executive Officer | Sell | 1,729 | $69.69 | $120.5K | 925,580 −0.2% of holding | |
| Goncalves Joana | Chief Medical Officer | Sell | 947 | $69.69 | $66.0K | 32,718 −2.8% of holding | |
| Quinlan Paul T | General Counsel | Sell | 733 | $69.69 | $51.1K | 31,034 −2.3% of holding | |
| Sandler Laura Lee | Chief Operating Officer | Sell | 600 | $69.69 | $41.8K | 236,384 −0.3% of holding | |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 395 | $69.69 | $27.5K | 16,899 −2.3% of holding | |
| Dambkowski Carl | Director | Sell 10b5-1 | 12,583 | $70.11 | $882.2K | 38,743 −24.5% of holding | |
| Agarwal Arjun 3 fills | Senior Vice President, Finance | Sell 10b5-1 | 9,459 | $69.72 | $659.5K | 24,894 −27.5% of holding | |
| Dambkowski Carl | Director | Sell 10b5-1 | 22,417 | $70.13 | $1.6M | 51,326 −30.4% of holding | |
| Dambkowski Carl 3 fills | Director | Sell 10b5-1 | 105,000 | $58.97 | $6.2M | 140,425 −42.8% of holding | |
| Agarwal Arjun 4 fills | Senior Vice President, Finance | Sell 10b5-1 | 10,290 | $59.07 | $607.8K | 22,506 −31.4% of holding | |
| Goncalves Joana 3 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $61.85 | $432.9K | 35,577 −16.4% of holding | |
| Sandler Laura Lee 6 fills | Chief Operating Officer | Sell 10b5-1 | 5,000 | $63.88 | $319.4K | 239,784 −2% of holding | |
| Goncalves Joana 3 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $66.12 | $462.8K | 36,150 −16.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.